No abstract available
Publication types
-
Consensus Development Conference
-
Practice Guideline
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Anemia / etiology
-
Anemia / prevention & control
-
Angioplasty, Balloon, Coronary / methods
-
Anticoagulants / therapeutic use
-
Biomarkers / metabolism
-
Blood Coagulation Factors / therapeutic use
-
Cardiotonic Agents / therapeutic use
-
Coronary Angiography
-
Coronary Disease / diagnosis*
-
Coronary Disease / etiology
-
Coronary Disease / therapy*
-
Diabetic Angiopathies / etiology
-
Diabetic Angiopathies / prevention & control
-
Diabetic Nephropathies / etiology
-
Diabetic Nephropathies / prevention & control
-
Diagnosis, Differential
-
Drug Interactions
-
Drug Resistance
-
Electrocardiography
-
Exercise Therapy / methods
-
Hemorrhage / etiology
-
Hemorrhage / prevention & control
-
Humans
-
Long-Term Care
-
Nitrates / therapeutic use
-
Physical Examination
-
Platelet Aggregation Inhibitors / therapeutic use
-
Risk Assessment / methods
-
Thrombin / antagonists & inhibitors
-
Vitamin K / antagonists & inhibitors
Substances
-
Adrenergic beta-Antagonists
-
Anticoagulants
-
Biomarkers
-
Blood Coagulation Factors
-
Cardiotonic Agents
-
Nitrates
-
Platelet Aggregation Inhibitors
-
Vitamin K
-
Thrombin